{"id":"https://openalex.org/W2946911728","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3086","title":"c-AMP/MAPK dysregulation and its impact on survival and response to immunotherapy in advanced melanomas.","display_name":"c-AMP/MAPK dysregulation and its impact on survival and response to immunotherapy in advanced melanomas.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2946911728","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3086","mag":"2946911728"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.3086","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3086","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.3086","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055625321","display_name":"Rami Nayef Al-Rohil","orcid":"https://orcid.org/0000-0002-9431-0530","observed_orcids":["https://orcid.org/0000-0002-9431-0530"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami Al-Rohil","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073728648","display_name":"Etan Marks","orcid":"https://orcid.org/0000-0002-4601-0285","observed_orcids":["https://orcid.org/0000-0002-4601-0285"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Etan Marks","raw_affiliation_strings":["NYU Langone, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone, New York, NY;","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018038165","display_name":"Varshini Vasudevaraja","orcid":"https://orcid.org/0000-0001-9678-6375","observed_orcids":["https://orcid.org/0000-0001-9678-6375"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Varshini Vasudevaraja","raw_affiliation_strings":["NYU Langone, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone, New York, NY;","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113842761","display_name":"Stephen Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Kelly","raw_affiliation_strings":["NYU Langone, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone, New York, NY;","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078452073","display_name":"Matija Snuderl","orcid":"https://orcid.org/0000-0003-0752-0917","observed_orcids":["https://orcid.org/0000-0003-0752-0917"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matija Snuderl","raw_affiliation_strings":["NYU Langone, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone, New York, NY;","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Buckner Johnson","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073836752","display_name":"George Jour","orcid":"https://orcid.org/0000-0001-8916-8966","observed_orcids":["https://orcid.org/0000-0001-8916-8966"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Jour","raw_affiliation_strings":["NYU Langone, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone, New York, NY;","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"3086","last_page":"3086"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.019600000232458115,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.7289999723434448},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9259999990463257},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/pde4dip","display_name":"PDE4DIP","score":0.902999997138977},{"id":"https://openalex.org/keywords/mtorc1","display_name":"mTORC1","score":0.9440000057220459},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7300000190734863},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6790000200271606},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8730000257492065},{"id":"https://openalex.org/keywords/epigenetic-dysregulation","display_name":"epigenetic dysregulation","score":0.7639999985694885}],"concepts":[{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.6663703918457031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6641724109649658},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5882147550582886},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.5860458612442017},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5420490503311157},{"id":"https://openalex.org/C140173407","wikidata":"https://www.wikidata.org/wiki/Q1138358","display_name":"CpG site","level":5,"score":0.5313851237297058},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5228983759880066},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4846285283565521},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.48146405816078186},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.4658452272415161},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4440978467464447},{"id":"https://openalex.org/C2780538058","wikidata":"https://www.wikidata.org/wiki/Q17917642","display_name":"ETS1","level":4,"score":0.4139527380466461},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40565451979637146},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36121028661727905},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.34339529275894165},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2342221736907959},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21988174319267273},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.21398189663887024},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.17227134108543396},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.16826418042182922}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.3086","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3086","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.3086","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2785351732","https://openalex.org/W2740207135","https://openalex.org/W4408389019","https://openalex.org/W2889720026","https://openalex.org/W3177104140","https://openalex.org/W2965059444","https://openalex.org/W2890105387","https://openalex.org/W2825393633","https://openalex.org/W3100392473","https://openalex.org/W7212000650"],"abstract_inverted_index":{"3086":[0],"Background:":[1],"Immunotherapies":[2],"blocking":[3],"the":[4,17,103],"interaction":[5],"of":[6,19,44,58,117,122,126,152,172,215,220,229],"CTLA-4":[7,89],"or":[8,124],"Programmed":[9],"Death":[10],"1":[11],"(PD-1)":[12],"with":[13,42,49,86,94,149,181,201,224],"their":[14],"ligands":[15],"are":[16,100],"standard":[18],"care":[20],"for":[21],"advanced":[22],"MEL":[23,81],"although":[24],"many":[25],"pts":[26],"fail":[27],"to":[28,35,231],"benefit":[29],"from":[30,83],"immunotherapy.":[31],"Herein,":[32],"we":[33],"seek":[34],"identify":[36],"epigenetic":[37,213],"and":[38,62,75,108,134,140,158,185,194,207,218,227],"genetic":[39],"signatures":[40],"associated":[41,180,200,223],"lack":[43,228],"response":[45,190,203,230],"in":[46,79,102,144,155,174],"patients":[47,84],"treated":[48,85],"immunotherapy":[50],".":[51,105,146],"Methods:":[52],"We":[53],"performed":[54],"whole":[55],"exome":[56],"sequencing":[57],"580":[59],"cancer-related":[60],"genes":[61],"whole-genome":[63],"DNA":[64],"methylation":[65,114],"arrays":[66],"targeting":[67],">":[68],"850k":[69],"CpG":[70],"sites":[71,78],"covering":[72],"promoters,":[73],"enhancers,":[74],"transcription":[76],"factor":[77],"28":[80],"samples":[82],"PD-1":[87],"+/-":[88],"inhibitors.":[90],"Findings":[91,99],"were":[92,179,199],"correlated":[93],"collected":[95],"clinical":[96],"history.":[97],"Results:":[98],"summarized":[101],"table":[104],"Unsupervised":[106],"clustering":[107],"multi-parametric":[109],"analysis":[110,131],"showed":[111],"a":[112,169,182],"distinct":[113],"signature":[115],"independent":[116],"age,":[118],"sex,":[119],"stage,":[120],"site":[121],"metastasis,":[123],"type":[125],"treatment":[127],"(adj.":[128,138],"p<0.01).":[129],"Pathway":[130],"identified":[132],"c-AMP/MAPK":[133],"PI3K-Akt":[135,159],"signaling":[136,217],"pathways":[137,160],"p=2.10E-05":[139],"8.19E-06,":[141],"respectively)":[142],"enrichment":[143],"non-responders":[145],"This":[147],"coincided":[148],"significant":[150],"increase":[151],"mutational":[153],"events":[154,165,198],"c":[156],"-AMP/MAPK":[157],"(p=":[161],"0.0001)":[162],"including":[163],"deleterious":[164,197],"affecting":[166],"PDE4DIP":[167,196,221],"(p=0.0002),":[168],"negative":[170],"regulator":[171],"mTORC1,":[173],"non-responders.":[175],"C-AMP/MAPK/PI3K":[176],"genomic":[177],"alterations":[178],"worse":[183,189,205,225],"OS":[184,206],"PFS":[186,208],"but":[187],"not":[188],"rate":[191],"(p=0.04,":[192],"p=0.01,":[193],"p=0.20).":[195],"decreased":[202],"rate,":[204],"(p=0.002;":[209],"p=0.002;p=0.00003).":[210],"Conclusions:":[211],"Convergent":[212],"dysregulation":[214],"cAMP/MAPK":[216],"inactivation":[219],"is":[222],"outcome":[226],"immunotherapy,":[232],"respectively.":[233],"[Table:":[234],"see":[235],"text]":[236]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-06-07T00:00:00"}